UCB (EBR:UCB) UCB Media Room: Disposal of own shares
Transparency directive : regulatory news
02/06/2022 20:00
https://mb.cision.com/Public/18595/3579081/aa15ba1a6ae1584f_800x800ar.png
** Disposal of own shares
------------------------------------------------------------
Brussels (Belgium), 2 June 2022 =E2=80=93 20:00 (CEST) =E2=80=93 Regulated =
information
In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB announces that, following an exercise=
of stock options by a member of its personnel, it has disposed of UCB shar=
es OTC in view of deliveries of these shares to the relevant member of the =
personnel, within the framework of the Long-Term Incentive Program of the U=
CB Group, as follows:
https://mb.cision.com/Public/18595/3579081/bb18449648d6b06c_800x800ar.png
This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://www.ucb.com/stories-media/Press-Releases) .
For further information, contact UCB:=C2=A0
Investor Relations
Antje Witte=C2=A0
T +32 2 559 94 14
antje.witte@ucb.com
Corporate Communications
Laurent Schots=C2=A0
T+32 2 559 92 64
laurent.schots@ucb.com =C2=A0=C2=A0 =C2=A0
About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With approximately 8 600 peopl=
e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.8 bi=
llion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us =
on Twitter: @UCB_news
=C2=A0
GenericFile
220602 - Disposals of own shares ENG (https://mb.cision.com/Public/18595/35=
79081/893be074d182ec02.pdf) GenericFile
220602 - Ali=C3=A9nation d actions propres FR (https://mb.cision.com/Public=
/18595/3579081/b6888b5caab21842.pdf) GenericFile
220602 - Vervreemding van eigen aandelen NL (https://mb.cision.com/Public/1=
8595/3579081/ac255a2696149a3b.pdf) Image
Chart 1 June 2 2022 (https://mb.cision.com/Public/18595/3579081/bb18449648d=
6b06c_org.png)
______________________
If you would rather not receive future communications from UCB SA, please g=
o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x107247x1x6868579x2400=
0x6&Email=3Dregnews%40symexglobal.com.
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium
UCB's latest news
22/04/2024 07:01
19/04/2024 20:00
17/04/2024 07:01
12/04/2024 20:00
12/04/2024 18:01
12/04/2024 07:01
11/04/2024 20:01
05/04/2024 20:01
04/04/2024 07:02
29/03/2024 20:00
Other stories
23/04/2024 19:03
23/04/2024 23:38
23/04/2024 22:20
23/04/2024 17:03
23/04/2024 21:20
23/04/2024 16:58
23/04/2024 20:05
23/04/2024 18:59
23/04/2024 18:29
23/04/2024 15:42
23/04/2024 20:58
23/04/2024 17:34
23/04/2024 22:41
23/04/2024 21:32
23/04/2024 23:02
23/04/2024 17:48
23/04/2024 19:30
23/04/2024 18:19
23/04/2024 22:10
23/04/2024 17:27
23/04/2024 19:32
23/04/2024 18:19
23/04/2024 18:57
23/04/2024 19:06
23/04/2024 18:35
24/04/2024 00:04
23/04/2024 22:59
23/04/2024 20:20
23/04/2024 23:21
23/04/2024 19:00
24/04/2024 01:01
22/04/2024 18:16
22/04/2024 21:46
23/04/2024 12:43
23/04/2024 20:17
23/04/2024 09:00
23/04/2024 03:13